Gerhard Gruber
30 Biopolis Str, #07-01 Matrix
Singapore, 138671, Singapore
Singapore, 138671, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
A Series of Pyrazolo-Quinazoline Amines Inhibits the Cytochrome bd Oxidase in Mycobacterium tuberculosis.
Journal: Journal of medicinal chemistry
Published: January 13, 2026
Treatment outcomes in Mycobacterium abscessus pulmonary disease: A systematic review.
Journal: Annals of the Academy of Medicine, Singapore
Published: December 20, 2025
The Inlet, Outlet, and New Ratchet Element for Proton Transfer of the Acinetobacter baumannii F-ATP Synthase and Their Critical Role for Viability.
Journal: ACS infectious diseases
Published: November 27, 2025
The Mycobacterium abscessus cytochrome bcc:aa3 oxidase structure paves the way for an agent targeting subunit QcrB.
Journal: Nature communications
Published: September 22, 2025
The Mycobacterium abscessus F-ATP synthase structure reveals mechanistic elements enabling rational drug design to combat NTM lung disease.
Journal: Structure (London, England : 1993)
Published: August 14, 2025
The N-Terminal Extension of the Mycobacterium avium Rel Protein Is a Dual Regulator of the Bifunctional Enzyme and Represents a Novel Target.
Journal: Antibiotics (Basel, Switzerland)
Published: July 28, 2025
Whole-Cell Study Unveils Critical Mechanistic Elements, Regulatory Elements, and Inhibitor Targets of the Mycobacterium abscessus Cytochrome bd Oxidase.
Journal: ACS infectious diseases
Published: April 08, 2025
Mycobacterium tuberculosis F-ATP Synthase Inhibitors and Targets.
Journal: Antibiotics (Basel, Switzerland)
Published: October 30, 2024
Water occupancy in the Acinetobacter baumannii F-ATP synthase c-ring and its implications as a novel inhibitor target.
Journal: Structure (London, England : 1993)
Published: June 22, 2024
SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase.
Journal: The Journal of antimicrobial chemotherapy
Published: June 14, 2024
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876.
Journal: Microbiology spectrum
Published: November 20, 2023
Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline.
Journal: Biochemical and biophysical research communications
Published: November 07, 2023
Last Updated: 09/26/2026